Lautenschlager, Florian and Weiss, Manfred and Feuerer, Sigrun and Wodarz, Norbert (2022) Kratom - a short review for pain medicine. SCHMERZ, 36 (2). pp. 128-134. ISSN 0932-433X, 1432-2129
Full text not available from this repository. (Request a copy)Abstract
Background Consumption of the psychotropic plant kratom (botanical name: Mitragyna speciosa) is sometimes used for the self-medication of chronic or acute pain. An increase in the use is possible in Germany in the future. Objective This review provides an overview on kratom for pain specialists. The topics of the review are the pharmacological aspects, the mental effects, the effects on pain and the risks of kratom including possible addiction. Material and methods We conducted a review of literature in PubMed published until 15 January 2021 resulting in 426 publications of which 8 were specifically concerned with the topic of kratom and pain. Results In addition to other alkaloids, kratom also contains 7-hydroxymitragynine, which is active on opioid receptors. The use of kratom is not without risks, e.g. because there is no standardized form of administration as well as the possibility of direct damage to health and of addiction. Discussion There are currently no evidence-based reasons to recommend the use of kratom as an analgesic. It is important for pain specialists to ask patients about a possible abuse of kratom and to be able to inform the patients about the potential risks of kratom.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | MITRAGYNINE; Pharmacology; Pain specialists; Addiction medicine; Risks; Pain |
| Subjects: | 600 Technology > 610 Medical sciences Medicine 600 Technology > 615 Pharmacy |
| Divisions: | Medicine > Lehrstuhl für Psychiatrie und Psychotherapie |
| Depositing User: | Petra Gürster |
| Date Deposited: | 29 Nov 2022 06:04 |
| Last Modified: | 29 Nov 2022 06:06 |
| URI: | https://pred.uni-regensburg.de/id/eprint/46288 |
Actions (login required)
 |
View Item |
